TFCP
ABBV icon

Twin Focus Capital Partners’s AbbVie ABBV Stock Holding History

Twin Focus Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,082
Closed -$247K – 174
2025
Q4 		$247K Buy
1,082
+57
+6% +$13K 0.03% 165
2025
Q3 		$237K Buy
+1,025
New +$209K 0.03% 168
2025
Q2 		– Sell
-1,025
Closed -$215K – 168
2025
Q1 		$215K Buy
+1,025
New +$199K 0.03% 143
2024
Q4 		– Sell
-1,367
Closed -$270K – 142
2024
Q3 		$270K Hold
1,367
– – 0.04% 129
2024
Q2 		$234K Sell
1,367
-100
-7% -$16.6K 0.04% 130
2024
Q1 		$267K Sell
1,467
-486
-25% -$83.8K 0.05% 123
2023
Q4 		$303K Sell
1,953
-20
-1% -$2.92K 0.06% 120
2023
Q3 		$294K Sell
1,973
-1,216
-38% -$179K 0.07% 123
2023
Q2 		$430K Sell
3,189
-8
-0.3% -$1.17K 0.09% 123
2023
Q1 		$510K Buy
3,197
+26
+0.8% +$3.98K 0.1% 103
2022
Q4 		$512K Buy
3,171
+30
+1% +$4.6K 0.11% 100
2022
Q3 		$422K Buy
3,141
+56
+2% +$8.04K 0.1% 105
2022
Q2 		$472K Buy
3,085
+111
+4% +$17K 0.11% 101
2022
Q1 		$482K Buy
2,974
+85
+3% +$12.3K 0.09% 112
2021
Q4 		$391K Buy
2,889
+76
+3% +$8.98K 0.08% 134
2021
Q3 		$303K Buy
2,813
+484
+21% +$55.3K 0.07% 135
2021
Q2 		$262K Buy
2,329
+376
+19% +$42.3K 0.06% 154
2021
Q1 		$211K Buy
+1,953
New +$209K 0.06% 143
2020
Q3 		– Sell
-2,780
Closed -$273K – 147
2020
Q2 		$273K Buy
+2,780
New +$245K 0.11% 110

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Twin Focus Capital Partners's ABBV Position: Q1 2026 in Review

Twin Focus Capital Partners sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,082 shares — an estimated $247K sold.

Twin Focus Capital Partners first reported a position in ABBV in Q2 2020 and held it in 19 quarters. The position peaked at $512K in Q4 2022. 4,111 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Twin Focus Capital Partners reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Twin Focus Capital Partners sold 1,082 AbbVie shares in Q1 2026, an estimated $247K.
  • Twin Focus Capital Partners first reported a position in AbbVie in Q2 2020 and held it in 19 quarters.
  • Twin Focus Capital Partners's AbbVie position peaked at $512K in Q4 2022.
  • 4,111 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Twin Focus Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.